Company intelligence / Profile preview
AscentX Medical
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
Overview
AscentX Medical is developing advanced injectable regenerative therapies using autologous tissue engineering and microsphere technology, aiming to restore soft tissues and improve quality of life in aging populations. The company also offers cGMP aseptic fill and finish services as a CMO for the pharmaceutical and medical device industries. There are no disclosed clinical trial results or marketed products as of now.
- Therapeutic areas
- Other
- Modalities
- Injectable regenerative therapyAutologous tissue engineeringInjectable microspheres
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on AscentX Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AscentX Medical.